Chemokines as mediators of diseases related to surgical conditions

Shock

Volumn 14, Issue 1, 2000, Pages 1-7

  Shames, Brian D ^a   Zallen, Garrett S ^a   McIntyre Jr , Robert C ^a   Bensard, Denis D ^b   Pulido, Edward J ^a   Miller, Stephanie A ^a   Pomerantz, Benjamin J ^a   Selzman, Craig H ^a   Meng, Xianzhong ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Acute respiratory distress syndrome; Atherosclerosis; Chemokine receptor; I B; Leukocytes; NF B; Organ rejection; Production receptors; Signaling

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHUK PROTEIN, HUMAN; CHUK PROTEIN, MOUSE; I KAPPA B KINASE; IKBKB PROTEIN, HUMAN; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, HUMAN; IKBKE PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ARTERIOSCLEROSIS; BIOSYNTHESIS; CLASSIFICATION; DRUG ANTAGONISM; DRUG EFFECT; ENTERITIS; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; HUMAN; MOUSE; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CHEMOKINES; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; I-KAPPA B KINASE; INFLAMMATORY BOWEL DISEASES; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NF-KAPPA B; POSTOPERATIVE COMPLICATIONS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, CHEMOKINE; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0034222909     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200014010-00001     Document Type: Review

References (102)

1. Luster FH: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436-445, 1998.
2. Locati M, Murphy PM: Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu Rev Med 50: 425-400, 1999.
3. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, Greaves DR, Zlotnik A, Schall TJ: A new class of membrane-bound chemokine with a CX3C motif. Nature 385:640-644, 1997.
4. Keiner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, et al: Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-1399, 1994.
5. Mackay CR: Chemokines: what chemokine is that? Curr Biol 7:R384-R386, 1997.
6. Gale LM, McColl SR: Chemokines: extracellular messengers for all occasions? BioEssays 21:17-28, 1999.
7. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol 55:97-179, 1994.
8. Roebuck KA, Carpenter LR, Lakshminarayanan V, Page SM, Moy JN, Thomas LL: Stimulus-specific regulation of chemokine expression involves differential activation of redox-responsive transcription factors AP-1 and NF-κB. J Leukoc Biol 65:291-298, 1999.
9. Yiyang X, Pauza ME, Feng L, Lo D: RelB regulation of chemokine expression modulates local inflammation. Am J Pathol 151:375-387, 1997.
10. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994.
11. Shames BD, Selzman CH, Meng X, Meldrum DR, Cain BS, Harken AH: Genes don't count. Arch Surg 133:667-669, 1998.
12. Rollins BJ: Chemokines. Blood 90:909-928, 1997.
13. Nibbs RJ, Wylie SM, Yang J, Landau NR, Graham GJ: Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem 272:32078-32083, 1997.
14. Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, Steiner DF: Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CC10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol 16:1249-1256, 1997.
15. Zlotnik A, Morales J, Hedrick JA: Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19:1-47, 1999.
16. Murphy PM: The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 12:593, 1994.
17. Premack BA, Schall TJ: Chemokine receptors: gateways to inflammation and infection. Nat Med 2:1174-1178, 1996.
18. Bokoch GM: Chemoattractant signalling and leukocytes activation. Blood 86:1649-1660, 1995.
19. Loetscher P, Seitz M, Baggiolini M, Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 184:569-577, 1996.
20. Cummings CJ, Martin TR, Frevert CW, Quan JM, Wong VA, Mongovin SM, Hagen TR, Steinberg KP, Goodman RB: Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 162: 2341-2346, 1999.
21. Chuntharapai A, Lee J, Hebert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682-5688, 1994.
22. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101, 1994.
23. Furie MB, Randolph GJ: Chemokines and tissue injury. Am J Pathol 146:1287-1301, 1995.
24. Homeister JW, Zhang M, Frenette PS, Hynes RO, Wagner DD, Lowe JB, Marks RM: Overlapping functions of E- and P-selectin in neutrophil recruitment during acute inflammation. Blood 92:2345-2352, 1998.
25. Lynam E, Sklar LA, Taylor AD, Neelamegham S, Edwards BS, Smith CW, Simon SI: Beta2-integrins mediate stable adhesion in collisional interactions between neutrophils and ICAM-1 expressing cells. J Leukoc Biol 64:622-630, 1998.
26. Huber AR, Kunkel SL, Todd RF, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 254:99-102, 1991.
27. Detmers PA, Powell DE, Walz A, Clark-Lewis I, Baggiolini M, Cohn ZA: Differential effects of neutrophil-activating peptide 1/IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 147: 4211-4217, 1991.
28. Kuiipers TW, Hakkert BC, Hart MHL, Roos D: Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. J Cell Biol 117:565-572, 1992.
29. Smart SJ, Casale TB: TNF-α-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 266:L238-L245, 1994.
30. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H: Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88:2039-2046, 1991.
31. Randolph GJ, Furie MB: A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Immunol 155:3610-3618, 1995.
32. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M: Different functions for the interleukin 8 receptor (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93:6682-6686, 1996.
33. Wozniak A, Betts WH, Murphy GA, Rockicinski M: Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 79:608-615, 1993.
34. Rollins BJ, Walz A, Baggiolini M: Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:1112-1116, 1991.
35. Vaddi K, Newton RC: Comparison of biological responses of human monocytes and THP-1 cells to chemokines of the intercrine-b family. J Leukoc Biol 55:756-762, 1994.
36. Lee B, Montaner LJ: Chemokine immunobiology in HIV-1 pathogenesis. J Leukoc Biol 65:552-565, 1999.
37. Sachdeva SC, Guntupalli KK: Acute respiratory distress syndrome. Crit Care Clin 13:503-521, 1997.
38. Kollef MH, Schuster DP: The acute respiratory distress syndrome. N Engl J Med 334:27-37, 1995.
39. Lee CT, Fein AM, Lippmann M: Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304:192-196, 1981.
40. Baldwin SR, Grum CM, Boxer LA: Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet i:11-13, 1986.
41. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/ interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989.
42. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K: Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 56:559-564, 1994.
43. Miller EJ, Cohen AB, Matthay MA: Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome. Crit Care Med 24:1448-1454, 1996.
44. Donnelly TJ, Meade P, Jagels M, Cryer HG, Law MM, Hugh TE, Shoemaker WC, Abraham E: Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 22:768-776, 1994.
45. Miller EJ, Cohen AB, Nagao S, Griffith RJ, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146:427-432, 1992.
46. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patients. Lancet 341:643-647, 1993.
47. Chollet-Martin S, Montravers P, Gibert C, Elbim C, Desmonts JM, Fagon JY, Gougerot-Pocidalo MA: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immunol 61:4553-4559, 1993.
48. Villard J, Dayer-Pastore F, Harnacher J, Aubert JD, Schlegel-Haueter S, Nicod LP: GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med 152:1549-1554, 1995.
49. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistant elevation over time predicts poor outcome. Chest 108:1303-1314, 1995.
50. Osman MO, Kristensen JU, Jacobsen NO, Lausten SB, Deleuran B, Deleuran M, Gesser B, Matsushima K, Larsen CG, Jensen SL: A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbis. Gut 43:232-239, 1999.
51. Matsumoto T, Yokoi K, Mukaida N, Harada A, Yamashita J, Watanabe Y, Matsushima K: Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerbral reperfusion injury. J Leuko Biol 62:581-587, 1997.
52. Yokoi K, Mukaida N, Harada A, Wantanabe Y, Matsushima K: Prevention of endotoxemia-induced acute respiratory distress syndrome-like lung injury in rabbits by an monoclonal antibody to IL-8. Lab Invest 76:375-384, 1997.
53. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC: Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96:107-116, 1995.
54. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365:654-657, 1993.
55. Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, Chuntharapai A, Hebert CA: Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy. J Immunol 152:2960-2967, 1994.
56. Goodman RB, Streiter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR: Inflammatory cytokines in patients with persistance of acute respiratory distress syndrome. Am J Respir Crit Care Med 154:602-611, 1996.
57. Ongibene FC, Martin SE, Parker MM: Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 315:547-551, 1986.
58. Wortel CH, Doerschuk CM: Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome. New Horiz 1:631-637, 1993.
59. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP, Ward PA: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol 158:3439-3448, 1997.
60. Shanley TP, Schmal H, Friedl HJP, Jones ML, Ward PA: Role of macrophage inflammatory protein-1a (MIP-1a) in acute lung injury in rats. J Immunol 154:4793-4802, 1995.
61. Driscoll KE: Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 20:473-490, 1994.
62. Kalyanaraman M, Heidemann SM, Sarnaik AP: Macrophage inflammatory protein-2 predicts acute lung injury in endotoxemia. J Invest Med 46:275-278, 1998.
63. Gerard C, Frossard JL, Bahatia M, Saluja A, Gerard NP, Lu B, Steer M: Targeted disruption of the beta chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest 100:2022-2027, 1997.
64. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126, 1999.
65. Nelken NA, Coughlin SR, Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121-1127, 1991.
66. Yia-Hertuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Leonard EJ, Witztum JL, Steinberg D: Expression of monocyte chemoattractant 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256, 1991.
67. Boring L, Gosling J, Cleary M, Charo IF: Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-987, 1998.
68. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF: MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773-778, 1999.
69. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2:275-281, 1998.
70. Kolios G, Petoumenos C, Nakos A: Mediators of inflammation: production and implication in inflammatory bowel disease. Hepatogastroenterology 45:1601-1609, 1998.
71. MacDermott RP, Sanderson IR, Reinecker HC: The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 4:54-67, 1998.
72. Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR: Increased interleukin-8 (IL-8) in rectal sialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 94:704-712, 1999.
73. Arai F, Takahashi T, Furkawa K, Matsushima K, Asakura H: Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease. Dig Dis Sci 43:2071-2079, 1998.
74. Walz A, Schmutz P, Mueller C, Schnyder-Candrian S: Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol 62:604-611, 1997.
75. Z'Graggen K, Walz A, Mazzucchelli L, Stricter RM, Meuller C: The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 113:808-816, 1997.
76. Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216-222, 1996.
77. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Mueller C: Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 144:997-1007, 1994.
78. Wedemeyer J, Lorentz A, Goke M, Meir PN, Flemmining P, Dahinden CA, Manns CA, Bischoff SC: Enhanced production of monocyte chemotatic protein in inflammatory bowel disease mucosa. Gut 44:629-635, 1999.
79. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75:263-274, 1993.
80. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153:811-816, 1994.
81. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC, Harken AH: Therapeutic implications of interleukin-10 in surgical disease. Shock 10:309-318, 1998.
82. van Deventer SJ, Elson CO, Fedorak RN: Multiple doses of intravenous interleukin 10 in steroid refractory Crohn's disease. Crohn's disease study group. Gastroenterology 113:383-389, 1997.
83. Wang JD, Nonomura N, Takhara S, Li BS, Azuma H, Ichimaru N, Kokado Y, Matsumiya K, Miki T, Suzuki S, Okuyama A: Lymphotactin: a key regulator of lymphocyte trafficking during acute graft rejection. Immunology 95:56-61, 1998.
84. Hedrick JA, Saylor V, Figueroa D, Mizoue L, Xu Y, Menon S, Abrams J, Handel J, Zlotnik A: Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo. J Immunol 158:1533-1540, 1997.
85. Pattison J, Nelson PJ, Huie P, von Leuttichau I, Farshid G, Sibley RK, Krensky AM: RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 343:209-211, 1994.
86. + T cells produce RANTS during acute rejection of murine allogeneic skin grafts. Transplantation 67:854-864, 1999.
87. Azzawi M, Hasleton PS, Geraghty PJ, Yonan N, Krysiak P, Dieraniya AK, Hutchinson IV: RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages. J Heart Lung Transplant 17:881-887, 1998.
88. Russell ME, Adams DH, Wyner LR, Yamashita Y, Halnon NJ, Karnovsky MJ: Early and persistant induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc Natl Acad Sci USA 90:6086-6090, 1993.
89. Kondo T, Novivck AC, Toma H, Faichild RL: Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 61:1750-1757, 1996.
90. Eitner F, Cui Y, Hudkins KL, Alpers CE: Chemokine receptor (CXCR4) mRNA-expressing leukocytes are increased in human renal allograft rejection. Transplantation 66:1551-1557, 1998.
91. Bacon KB, Premack BA, Gardner P, Schall TJ: Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269:1727-1730, 1995.
92. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ: Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol 156:2095-2103, 1996.
93. Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, Murphy PM: Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med 185:1959-1968, 1997.
94. Zhou Y, Kurihara T, Ryseck RP, Yang Y, Ryan C, Loy J, Warr G, Bravo R: Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol 160:4018-4025, 1998.
95. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicyate and aspirin. Science 265:956-959, 1994.
96. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS: Role of transcriptional activation of IκBa in mediation of immunosuppression by glucocorticoids. Science 270:283-286, 1995.
97. Auphan N, DiDonato JA, Rosette C, Helmberg AMK: Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-290, 1995.
98. Stancovski I, Baltimore D: NF-KB activation: the IκB kinase revealed? Cell 91:299-302, 1997.
99. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554, 1997.
100. Trepicchio WL, Wang L, Bozza M, Dorner AJ: IL-11 regulates macrophage effector function through the inhibition of nuclear factor-κB. J Immunol 159:5661-5670, 1997.
101. Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, Meng X, Harken AH, McIntyre RC: Interleukin-10 stabilizes inhibitory-κB-a in human monocytes. Shock 10:389-394, 1998.
102. McFadden G, Kelvin D: New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road. Biochem Pharmacol 54:1271-1280, 1997.